Cantor BioConnect Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 2

Cantor BioConnect General Information

Description

Provider of biospecimen procurement and contract research services intended for the diagnostic and pharmaceutical industries. The company offers clinical sample collection, identification, and delivery of tissues, serum, and antibodies, designed to enable medical researchers to develop and validate life-saving treatments and diagnostic devices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 9456 Cuyamaca Street
  • Suite 101
  • Santee, CA 92071
  • United States
+1 (619)
Primary Industry
Pharmaceuticals
Corporate Office
  • 9456 Cuyamaca Street
  • Suite 101
  • Santee, CA 92071
  • United States
+1 (619)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cantor BioConnect Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cantor BioConnect‘s full profile, request access.

Request a free trial

Cantor BioConnect Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cantor BioConnect Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cantor BioConnect‘s full profile, request access.

Request a free trial

Cantor BioConnect Investments (2)

Cantor BioConnect’s most recent deal was a Buyout/LBO with Dx Biosamples. The deal was made on 30-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dx Biosamples 30-Jun-2026 Buyout/LBO Drug Discovery
Seraplex 23-Apr-2026 Buyout/LBO Distributors (Healthcare)
To view Cantor BioConnect’s complete investments history, request access »

Cantor BioConnect Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Dx Biosamples San Diego, CA 2010
Seraplex Pasadena, CA 1974

Cantor BioConnect FAQs

  • When was Cantor BioConnect founded?

    Cantor BioConnect was founded in 2016.

  • Where is Cantor BioConnect headquartered?

    Cantor BioConnect is headquartered in Santee, CA.

  • What is the size of Cantor BioConnect?

    Cantor BioConnect has 9 total employees.

  • What industry is Cantor BioConnect in?

    Cantor BioConnect’s primary industry is Pharmaceuticals.

  • Is Cantor BioConnect a private or public company?

    Cantor BioConnect is a Private company.

  • What is Cantor BioConnect’s current revenue?

    The current revenue for Cantor BioConnect is .

  • Who are Cantor BioConnect’s investors?

    Prairie Capital has invested in Cantor BioConnect.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process